glp-1 heart disease receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential Modulatory Role of GLP-1 Receptor
Description
95% CI 0.750.98, p=0.03), Dulaglutide (RR 0.82, 95% CI 0.700.96, p=0.02), Albiglutide (RR 0.93,95% CI 0.791.10, p=0.40), Exenatide (RR 0.93, 95% CI 0.741.18, p=0.55), Lixisenatide (RR 0.83, 95% CI 0.621.12, p=0.22), and Efpeglenatide (RR 0.76, 95% CI 0.461.24, p=0.27)
We're not at "GLP-1s treat depression." We're at "GLP-1s are teaching us something profound about how the body and mind regulate each other and we need to pay careful attention to who benefits and who doesn't." That's worth being excited about
Because GLP-1 also has potential anti-inflammatory properties, it can contribute to a healthier gut lining, thus preventing gastrointestinal problems in the long term
Daily insulin users: every 2-4 weeks
Weekly injectable Semaglutide for lasting weight management
